Current Edition

Volume 14 Issue 2

COVID-19 and Sepsis Co-infection: The Impact of Advanced Detection and Diagnosis

Sepsis is characterised as life-threatening and fast-progressing organ dysfunction caused by a dysregulated host response to infection. Sepsis shares several clinical manifestations with COVID-19, making …

Continue Reading →
Volume 14 Issue 2

Transforming the Status Quo Through Digitalisation and AI

For all the extraordinary innovations made in the field of medical science, in many ways we are still working in the dark. Take renal transplants. …

Continue Reading →
Volume 14 Issue 2

The Importance of User Insights in Digital Product Design

Gathering user insights should be a key part of any medical device development. Understanding your user’s context of use, behaviours and views can allow you …

Continue Reading →
Volume 14 Issue 2

Does Remote Pharma GMP Auditing have a Future?

The two years since COVID struck, have seen virtual auditing checks and inspections take the place of on-site visits. Some auditors believe that the tools …

Continue Reading →
Volume 14 Issue 2

New Manufacturing Technology Platforms for Biosimilars

Innovation in process and bioreactor technology, a better understanding of cell lines, advances in analytical methods and equipment, continuous processing, and single-use technologies, have accelerated, …

Continue Reading →
Volume 14 Issue 2

Big Strides in Small Batch Aseptic Processing

Growing demand for small-batch processing poses new challenges for the life sciences sector. Adapting to variances while maintaining quality, efficiency and adherence to aseptic processing …

Continue Reading →
Volume 14 Issue 2

Making a Case for a Fixed Dose Combination Drug Strategy

Over the past two decades, pharma’s acute focus on the patient has driven great innovation and investment in ways to deliver active pharmaceutical ingredients (APIs) …

Continue Reading →
Volume 14 Issue 2

Tackling Pharma’s Shadow Market: Getting ‘Smarter’ in the Fight Against Fake Pharmaceuticals

If you were to ask a member of the public “what is the world’s most counterfeited product?”, it’s highly likely they’ll say designer handbags or …

Continue Reading →
Volume 14 Issue 2

Shared Care: Strengthening Self-management Support for Chronic Patients

In recent years, converging healthcare trends have been creating more empowered patients. Before the pandemic, patients could already monitor their own condition through connected devices …

Continue Reading →
Volume 14 Issue 2

The Benefits of Patient Centricity in Clinical Trials: How it can Support Clinical Operations and Study Adherence

Patient centricity in clinical operations and study adherence is growing in popularity. A patient-centric approach means that the needs of patients are placed at the …

Continue Reading →